ID PINX1_MOUSE Reviewed; 332 AA. AC Q9CZX5; Q14BS4; Q3V450; Q8C6E5; Q91WZ9; Q9D0C2; DT 20-JUN-2002, integrated into UniProtKB/Swiss-Prot. DT 20-JUN-2002, sequence version 2. DT 27-MAR-2024, entry version 144. DE RecName: Full=PIN2/TERF1-interacting telomerase inhibitor 1; DE AltName: Full=67-11-3 protein; DE AltName: Full=LPTS1; DE AltName: Full=Liver-related putative tumor suppressor; DE AltName: Full=Pin2-interacting protein X1; DE AltName: Full=TRF1-interacting protein 1; GN Name=Pinx1; Synonyms=Lpts; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=11701125; DOI=10.1016/s0092-8674(01)00538-4; RA Zhou X.Z., Lu K.P.; RT "The Pin2/TRF1-interacting protein PinX1 is a potent telomerase RT inhibitor."; RL Cell 107:347-359(2001). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=ICR; RA Liao C., Zhao M., Li T.; RT "The expression of mouse LPTS1, a homolog of human tumor suppressor LPTS, RT in mouse liver."; RL Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Embryo, and Stomach; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP NUCLEOTIDE SEQUENCE [MRNA] OF 38-332. RC TISSUE=Embryo; RA Schmidt T.; RL Thesis (2001), University of Goettingen, Germany. RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-233; SER-269; SER-274 AND RP SER-277, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Kidney, Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Microtubule-binding protein essential for faithful chromosome CC segregation. Mediates TRF1 and TERT accumulation in nucleolus and CC enhances TRF1 binding to telomeres. Inhibits telomerase activity. May CC inhibit cell proliferation and act as tumor suppressor (By similarity). CC {ECO:0000250}. CC -!- SUBUNIT: Interacts with MCRS1, TERT, TERF1, NCL/nucleolin, and the CC telomerase RNA. {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Nucleus, nucleolus CC {ECO:0000250}. Chromosome, telomere {ECO:0000250}. Chromosome, CC centromere, kinetochore {ECO:0000250}. Note=Localizes in nucleoli, at CC telomere speckles and to the outer plate of kinetochores. Localization CC to the kinetochore is mediated by its central region and depends on CC NDC80 and CENPE (By similarity). {ECO:0000250}. CC -!- DOMAIN: The TID (telomerase inhibiting domain) domain is sufficient to CC bind TERT and inhibits its activity. {ECO:0000250}. CC -!- DOMAIN: The TBM domain mediates interaction with TERF1. {ECO:0000250}. CC -!- SIMILARITY: Belongs to the PINX1 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF421879; AAL32445.1; -; mRNA. DR EMBL; AF321817; AAL37221.1; -; mRNA. DR EMBL; AK011578; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; AK012057; BAE43228.1; -; mRNA. DR EMBL; AK075840; BAC35998.1; -; mRNA. DR EMBL; BC115636; AAI15637.1; -; mRNA. DR EMBL; AJ344106; CAC51439.1; -; mRNA. DR CCDS; CCDS27205.1; -. DR RefSeq; NP_082504.1; NM_028228.3. DR AlphaFoldDB; Q9CZX5; -. DR BioGRID; 215357; 34. DR STRING; 10090.ENSMUSP00000022528; -. DR iPTMnet; Q9CZX5; -. DR PhosphoSitePlus; Q9CZX5; -. DR EPD; Q9CZX5; -. DR jPOST; Q9CZX5; -. DR MaxQB; Q9CZX5; -. DR PaxDb; 10090-ENSMUSP00000022528; -. DR PeptideAtlas; Q9CZX5; -. DR ProteomicsDB; 289577; -. DR Pumba; Q9CZX5; -. DR Antibodypedia; 54507; 291 antibodies from 31 providers. DR DNASU; 72400; -. DR Ensembl; ENSMUST00000022528.6; ENSMUSP00000022528.5; ENSMUSG00000021958.6. DR GeneID; 72400; -. DR KEGG; mmu:72400; -. DR UCSC; uc007uhx.2; mouse. DR AGR; MGI:1919650; -. DR CTD; 54984; -. DR MGI; MGI:1919650; Pinx1. DR VEuPathDB; HostDB:ENSMUSG00000021958; -. DR eggNOG; KOG2809; Eukaryota. DR GeneTree; ENSGT00450000040279; -. DR HOGENOM; CLU_047471_0_0_1; -. DR InParanoid; Q9CZX5; -. DR OMA; PCWDQSS; -. DR OrthoDB; 2919396at2759; -. DR PhylomeDB; Q9CZX5; -. DR TreeFam; TF321918; -. DR BioGRID-ORCS; 72400; 17 hits in 82 CRISPR screens. DR ChiTaRS; Pinx1; mouse. DR PRO; PR:Q9CZX5; -. DR Proteomes; UP000000589; Chromosome 14. DR RNAct; Q9CZX5; Protein. DR Bgee; ENSMUSG00000021958; Expressed in undifferentiated genital tubercle and 248 other cell types or tissues. DR GO; GO:0000781; C:chromosome, telomeric region; ISO:MGI. DR GO; GO:0000776; C:kinetochore; ISO:MGI. DR GO; GO:0005739; C:mitochondrion; ISO:MGI. DR GO; GO:0000228; C:nuclear chromosome; ISO:MGI. DR GO; GO:0005730; C:nucleolus; ISO:MGI. DR GO; GO:0005654; C:nucleoplasm; ISO:MGI. DR GO; GO:0005819; C:spindle; ISO:MGI. DR GO; GO:0044877; F:protein-containing complex binding; ISO:MGI. DR GO; GO:0010521; F:telomerase inhibitor activity; ISO:MGI. DR GO; GO:0070034; F:telomerase RNA binding; ISO:MGI. DR GO; GO:0007080; P:mitotic metaphase chromosome alignment; ISO:MGI. DR GO; GO:0010972; P:negative regulation of G2/M transition of mitotic cell cycle; ISO:MGI. DR GO; GO:0031397; P:negative regulation of protein ubiquitination; ISO:MGI. DR GO; GO:0032211; P:negative regulation of telomere maintenance via telomerase; ISO:MGI. DR GO; GO:1904751; P:positive regulation of protein localization to nucleolus; ISO:MGI. DR GO; GO:0070198; P:protein localization to chromosome, telomeric region; ISO:MGI. DR GO; GO:1902570; P:protein localization to nucleolus; ISO:MGI. DR GO; GO:0031647; P:regulation of protein stability; ISO:MGI. DR GO; GO:0007004; P:telomere maintenance via telomerase; ISO:MGI. DR InterPro; IPR000467; G_patch_dom. DR PANTHER; PTHR23149; G PATCH DOMAIN CONTAINING PROTEIN; 1. DR PANTHER; PTHR23149:SF27; PIN2_TERF1-INTERACTING TELOMERASE INHIBITOR 1; 1. DR Pfam; PF01585; G-patch; 1. DR SMART; SM00443; G_patch; 1. DR PROSITE; PS50174; G_PATCH; 1. DR Genevisible; Q9CZX5; MM. PE 1: Evidence at protein level; KW Centromere; Chromosome; Kinetochore; Nucleus; Phosphoprotein; KW Reference proteome; Telomere; Tumor suppressor. FT CHAIN 1..332 FT /note="PIN2/TERF1-interacting telomerase inhibitor 1" FT /id="PRO_0000058444" FT DOMAIN 26..72 FT /note="G-patch" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00092" FT REGION 1..27 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 196..332 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 254..328 FT /note="Telomerase inhibitory domain (TID)" FT MOTIF 291..301 FT /note="TBM" FT COMPBIAS 1..15 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 210..236 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 248..266 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 306..322 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 233 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 269 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 274 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 277 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT CONFLICT 40 FT /note="S -> A (in Ref. 3; BAC35998)" FT /evidence="ECO:0000305" FT CONFLICT 210..213 FT /note="ETPV -> HAPC (in Ref. 3; BAE43228)" FT /evidence="ECO:0000305" SQ SEQUENCE 332 AA; 37221 MW; 6B7147CED58D991A CRC64; MSMLAERRRK QKWTVDPRNT AWSNDDSKFG QKMLEKMGWS KGKGLGAQEQ GATEHIKVKV KNNHLGLGAT NNNEDNWIAH QDDFNQLLAA LNTCHGQETA DSSDKKEKKS FSLEEKSKIS KNRVHYMKFT KGKDLSSRSE TDLDCIFGKR RNKKLAQDGC SNSSADEVNT SLTTTTTTTS AFTIQEYFAK RMAQLKNKPQ ASAPGSDLSE TPVERKKGKK KNKEAADTDV ENSPQHKAKR HKKKKRVEAE RGPVAKKRDR AELQPGGPSE DECSDASVEA AEDCVQTPDI QDDVPKPKKR KAKKKLQRPE GVEIDATLDR APVKKKKKKV SR //